Date Announced | ticker | Company Name | Period | Period Year | Min EPS | Max EPS | Estimate | Min Rev | Max Rev | Revenue Estimate | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
02/06/2024 | GILD | Gilead Sciences | FY | 2024 | $6.85 | $7.25 | $7.21 | $27.10B | $27.50B | $27.66B | Get Alert |
11/07/2023 | GILD | Gilead Sciences | FY | 2023 | $6.65 | $6.85 | $6.25 | $26.70B | $26.90B | $25.34B | Get Alert |
08/03/2023 | GILD | Gilead Sciences | FY | 2023 | $6.45 | $6.80 | $6.73 | $26.30B | $26.70B | $26.66B | Get Alert |
04/27/2023 | GILD | Gilead Sciences | FY | 2023 | $6.60 | $7.00 | $6.84 | $26.00B | $26.50B | $26.73B | Get Alert |
02/02/2023 | GILD | Gilead Sciences | FY | 2023 | $6.60 | $7.00 | $6.73 | $26.00B | $26.50B | $25.76B | Get Alert |
10/27/2022 | GILD | Gilead Sciences | FY | 2022 | $6.95 | $7.15 | $6.54 | $25.90B | $26.20B | $25.25B | Get Alert |
08/02/2022 | GILD | Gilead Sciences | FY | 2022 | $6.35 | $6.75 | $6.57 | $24.50B | $25.00B | $24.57B | Get Alert |
04/28/2022 | GILD | Gilead Sciences | FY | 2022 | $6.20 | $6.70 | $6.50 | $23.80B | $24.30B | $24.48B | Get Alert |
02/01/2022 | GILD | Gilead Sciences | FY | 2022 | $6.20 | $6.70 | $6.91 | $23.80B | $24.30B | $24.39B | Get Alert |
10/28/2021 | GILD | Gilead Sciences | FY | 2021 | $7.90 | $8.10 | $7.18 | $26.00B | $26.30B | $25.12B | Get Alert |
07/29/2021 | GILD | Gilead Sciences | FY | 2021 | $6.90 | $7.25 | $7.07 | $24.40B | $25.00B | $24.64B | Get Alert |
04/29/2021 | GILD | Gilead Sciences | FY | 2021 | $6.75 | $7.45 | $7.17 | $21.70B | $22.10B | $24.78B | Get Alert |
02/04/2021 | GILD | Gilead Sciences | FY | 2021 | $6.75 | $7.45 | $6.85 | $21.70B | $22.10B | $24.27B | Get Alert |
01/11/2021 | GILD | Gilead Sciences | FY | 2020 | $6.98 | $7.08 | $6.61 | $24.30B | $24.35B | $23.71B | Get Alert |
10/28/2020 | GILD | Gilead Sciences | FY | 2020 | $6.25 | $6.60 | $6.98 | $23.00B | $23.50B | $24.17B | Get Alert |
07/30/2020 | GILD | Gilead Sciences | FY | 2020 | $6.25 | $7.65 | $6.71 | $23.00B | $25.00B | $23.44B | Get Alert |
02/04/2020 | GILD | Gilead Sciences | FY | 2020 | $6.05 | $6.45 | $7.01 | $21.80B | $22.20B | $22.56B | Get Alert |
07/30/2019 | GILD | Gilead Sciences | FY | 2019 | — | — | — | $21.60B | $22.10B | $22.06B | Get Alert |
The last reported Earnings numbers were from February 6, 2024 for the full year 2024 and was for an earnings per share guidance in the range of $6.85 and $7.25 versus the estimated EPS of $7.21.
Browse guidance and forecast on all stocks.